IconOVir Bio
Operator of a preclinical-stage biotechnology company intended to improve the treatment of patients with cancer. The company's proprietary oncolytic virus platform is designed to address key limitatio...
Valuation
$0
Share Price
N/A
Total Raised
$97.2M
Last Round
N/A